Nicotinic acetylcholine receptors (nAChRs) have been reported to be overexpressed in 1 4 malignancies in humans and is associated with tumorigenesis and cell migration. In previous 1 5 studies of gastric cancer, alpha7 nicotinic acetylcholine receptor (α7-nAChR) overexpression can 1 6 induce epithelial-mesenchymal transition (EMT) and promote migration of gastric cancer cells.
Introduction
Stomach cancer is the fifth most common malignancy and the third major cause in 3 4 cancer-related deaths in the word [1] .Moreover, the death rate of stomach cancer is the 3 5 second highest among all cancer related deaths in China [2] . It is difficult to detect the 3 6 early stages of gastric cancer and there are an overwhelming number of patients who 3 7 are diagnosed at the advanced stages of disease [3] .Therefore, the study of the 3 8 mechanisms of cancer cell migration mechanism during stomach cancer is of great 3 9 significance for new drug discoveries and for the development of effective treatments 4 0 for gastric cancer. Currently, the main treatment of gastric cancer consists only of 4 1 surgical treatment, radiotherapy and chemotherapy. However, these methods are 4 2 accompanied by poor patient prognosis with advanced gastric cancer and therefore a 4 3 novel treatment is urgently needed for people affected by this devastating disease. 4 4 Nicotinic acetylcholine receptors (nAChRs) are a type of ligand-gated ion channel 4 5 proteins, and their expression is not only found in neuronal cells but also in 4 6 NDV and PBS treated groups in which cell were infected by rL-RVG,NDV or PBS 1 1 1 for 24 h. Groups pretreated with ACB, MLA, si-RNA or corynoxeine for 24 h were 1 1 2 also set up. When cells reached 80% confluency, cell monolayers were wounded with 1 1 3 a 10 μ L pipette tip after 24 h and their wound healing ability was observed by 1 1 4 microscopy. 1 1 5 Migration Assay 1 1 6 To carry out migration assay 24-well plate transwell units with polycarbonate 1 1 7 membrane (8.0μm pore size;Costar,MA,USA) were used for in-vitro experiments 1 1 8 according to the manufacturer's protocol. In short, the upper chamber of filter inserts 1 1 9 contained serum free medium with 1×10 5 cells belonging to one of the treatment 1 2 0 groups: rL-RVG, NDV, PBS, MLA, ACB, si-RNA of α 7-nAChR or corynoxenine. Meanwhile, the lower chamber was filled with 600 μ L 10% serum media. After 1 2 2 incubation at 37°C in 5%CO 2 for 24 h, the media in the lower chamber were collected 1 2 3 and then non migrating cells attached to the membrane of the upper chamber surface 1 2 4 were scrubbed. Finally, cells on the bottom wells were stained with 0.1% crystal 1 2 5 violet for 20 minutes ,and then washed with PBS for 3 times. Lastly, the migrating 1 2 6 cells were counted under the microscope and analyzed by using Image-J software. 1 2 7 (National Institutes of Health,USA). Western Blot Analysis 1 2 9 After pre-treatment with MLA or ACB or si-RNA of α 7-nAChR or corynoxenine for 1 3 0 12 h，cells were infected for 24 h with either rL-RVG,NDV or PBS and then washed 1 3 1 with ice-cold PBS for 3 times and lysed by using the lysis buffer RIPA containing 1 1 3 2 mM PMSF for 30 minutes on ice. Next the lysates were collected and the protein 1 3 3 concentrations were quantified using a BCA kit (Thermo Fisher Scientific, 1 3 4 USA).Equal quantities of protein were separated by using a 10% SDS-PAGE and the 1 3 5 proteins were then transferred to polyvinylidinedifluoride (PVDF) membranes 1 3 6 (Bio-Rad Laboratories). The membranes were then blocked with 5% BSA in 1 3 7 Tris-buffered saline containing 0.1% Tween 20 (TBST, at pH 7.5) for about 2 hours at 1 3 8 room temperature before washing them with TBST for 15 minutes for 3 times. Next 1 3 9 the membranes were incubated with antibodies at 4˚C overnight with the following 1 4 0 antibodies: anti-α7 nAChR, anti-P-MEK, anti-MEK, anti-P-ERK, anti-ERK, 1 4 1 anti-E-cadherin, anti-N-cadherin and anti-Vementin. Proteins were detected with 1 4 2 HRP-conjugated secondary antibodies for 1 h at room temperature. The protein bands 1 4 3 were visualized with a Typhoon 9400 variable mode imager (Amersham Biosciences, 1 4 4 UK) using chemiluminescence (ECL Plus Substrate, Thermo Fisher Scientific, USA). Immunofluorescent Assay 1 4 6 BGC and SGC cells were added into 24-well plates and fixed with 4% 1 4 7 paraformaldehyde for 2 h at room temperature. Cells were then permeabilized with 1 4 8 0.5 % TritonX-100 in PBS for 10 minutes and blocked with 5% BSA for 1 h. Next the 1 4 9 cells were washed 3 times with PBS for 5 min before incubating them with 1 5 0 anti-P-ERK at 4˚C overnight. On the next day, the secondary antibody was used to 1 5 1 stain cells in order to be detected for immunofluorescence microscopy. After infection of BGC, SGC cells with rL-RVG, NDV and PBS for 24 h, the cells 1 5 4 were subcutaneously injected into axillary subcutaneous tissues of adult female 1 5 5 athymic-nude mice which were randomly selected for the treatment with either 1 5 6 rL-RVG,NDV or PBS and housed under specific pathogen free conditions. The size of 1 5 7 subcutaneous tumors that developed were measured 2 weeks post treatment using the 1 5 8 following calculation: V=W 2 L0.5 (V is volume, W is width and L is length). Statistical Analysis 1 6 0 All collected experimental data is presented as mean ± SD. A Student's t-test or one 1 6 1 -way ANOVA with Bonferroni post-test was used to calculate statistical significance 1 6 2 using the GraphPad Prism7.0 software (La Jolla,CA, USA). A p-value of P<0.05 or 1 6 3 P<0.01 was considered statistically significant. Each experiment was conducted 1 6 4 independently and repeated at least 3 times. 1 6 7 To investigate the mechanism of rL-RVG suppressing the migration of gastric cancer 1 6 8 cells, we first analyzed the expression of rL-RVG and NDV proteins in gastric cancer. 1 6 9 Previous studies show that lung cancer cell exhibit a stable expression of RVG and 1 7 0 NDV proteins by PCR, Western blot and immunofluorescence microscopy [16] .In our 1 7 1 study, we used Western blot to analyze both RVG and NDV protein expression in 1 7 2 virally infected gastric cancer cells and found that RVG proteins were only expressed 
RVG and NDV protein expression in gastric cancer cells

rL-RVG suppressed the proliferation and migration of gastric cancer cells 1 7 6
Metastasis is a big hurdle in the management of gastric cancer. To study metastasis 1 7 7 migration we used a transwell based and wound healing assay to monitor the 1 7 8
influence of viruses on gastric cancer cells migration. After infecting cells with 1 7 9
rL-RVG or NDV for 24 h, we observed that rL-RVG and NDV both reduced the 1 8 0 migration of gastric cancer cells compared to the PBS treated group. Of note is that 1 8 1 the inhibitory migration was stronger in rL-RVG treated cells compared to the NDV 1 8 2 group (Fig 2A,B) .Moreover, we found that rL-RVG had an inhibitory influence on the 1 8 3 migration of both SGC and BGC and SGC-7901 cells and were therefore selected for 1 8 4 further analysis in subsequent experiments. 1 8 5 To detect the viability of gastric cancer cells SGC7901 and BGC cells were infecting 1 8 6 with rL-RVG or NDV for 24 h and analysed using a CCK8 assay. rL-RVG and NDV 1 8 7 both suppressed cell proliferation in a concentration-dependent manner but overall 1 8 8 rL-RVG had a stronger inhibitory effect on proliferation compared to NDV and the 1 8 9 PBS control group. If rL-RVG and NDV were diluted to 10 3 and 10 2 respectively, the 1 9 0 viability of SGC and BGC cells was higher than 80%, and the viral titer was 1 9 1 approximately 10 9.8 EID 50 /mL (Fig 2C,D) . The role of α 7-nAChR in the process of rL-RVG regulated migratory abilities of 1 9 3 gastric cancer cells 1 9 4 The expression of α 7-nAChR in the rL-RVG and NDV groups was higher compared 1 9 5 with PBS group using Western Blot analysis. However the cell migratory ability in 1 9 6 1 0
both the rL-RVG and NDV group was suppressed compared with the PBS control 1 9 7 blank group. rL-RVG suppressed the migration more potently compared with the 1 9 8 NDV and PBS groups (Fig 1A,Fig 2A,B) . Further exploration regarding the role of 1 9 9 α 7-nAChR in rL-RVG on the suppression of the migration of gastric cancer cells is 2 0 0 necessary and the following treatments were performed. MLA , an antagonist of α 7-nAChR was used to pre-treat SGC7901 cells for 24 h 2 0 2 before infecting them with virus. Our result show that α 7-nAChR expression was 2 0 3 inhibited in a competitive manner and moreover, the migration of SGC7901 cells was 2 0 4 more suppressed in the MLA pre-treatment groups compared to the not pre-treated 2 0 5 groups as shown in our migration and wound healing assays. This result suggests that 2 0 6 rL-RVG may suppress cell migration through the α 7-nAChR pathway (Fig 4A,B ). To further verify the role of α 7-nAChR in rL-RVG-induced cells migration, we used 2 0 8 small interfering RNA methods to knock down the expression of α 7-nAChR. We 2 0 9
found that our results were consistent with the groups pre-treated with MLA. Therefore, rL-RVG may play a role as competitive antagonist of α 7-nAChR to inhibit 2 1 1 the migration of SGC7901 cells (Fig 5A,B) . In support of these results we found that ACB, an agonist of α 7-nAChR stimulates the 2 1 3 expression of α 7-nAChR ( Fig 3A,B) . In contrast to this, we got the opposite result when comparing our result with MLA or si-RNA pre-treated cells. Thus, rL-RVG 2 1 5 suppresses the migration of SGC7901 cells by inhibiting α 7-nAChR competitively. gastric cancer cell 2 1 8 It was shown previously that α 7-nAChR activates several signaling pathways in 2 1 9 connection with tumorigenic effects including the MEK/ERK pathway [8] . The role of unclear. Western blot analysis showed that rL-RVG induces the down-regulation of 2 2 3 phosphorylation levels of ERK1/2 when α 7-nAChR expression was blocked by 2 2 4 rL-RVG. Furthermore the migratory ability of gastric cancer cells was also reduced. Consistent with these results we showed by immunofluorescence that the expression 2 2 6 level of P-ERK was down-regulated after being infected with either rL-RVG or NDV 2 2 7 but was lower in the rL-RVG group compared with the NDV and PBS blank control 2 2 8 group (Fig 1 A,B and Fig 2 A,B ). To further support our results we showed that the level of ERK1/2 phosphorylation 2 3 0 was lower compared with the non pretreated groups after prtreatment with MLA or and Fig 5A,C) . Our migration and wound healing assay showed that the migratory 2 3 3 ability of SGC cells in the pretreated group decreased more compared to non 2 3 4 pretreated cells ( Fig 4B and Fig 5B) . To clarify whether rL-RVG modulates the 2 3 5 MEK/ERK signaling pathway to suppress cell migration, corynoxenine, an inhibitor 2 3 6 of the MEK/ERK pathway, was used to pre-treat gastric cancer cells (Fig 6A-C) .We 2 3 7 obtained comparable results in the groups treated with MLA and si-RNA of 2 3 8 α 7-nAChR as described above .However, opposite results were obtained when cells 1 2 were pre-treated with ACB ( Fig 3A-C) . These results indicate that rL-RVG attenuates 2 4 0 the activation levels of MEK/ERK pathway via blocking α 7-nAChR by competition. In our study Western blot analysis revealed that the protein expression level of 2 4 3 E-cadherin was increased while N-cadherin, and Vimentin were decreased in the 2 4 4 rL-RVG or NDV groups compared with the PBS treated control group (Fig 1A) . 2 4 5 Furthermore, the groups pre-treated with MLA showed that the expression of 2 4 6 E-cadherin was lower and the expression of N-cadherin and Vimentin was higher 2 4 7 compared with the non-pretreated groups using western blot ananlysis (Fig 4A, D) . 2 4 8 We found similar results after the pretreatment with the si-RNA of α 7-nAChR ( Fig 5A,  2  4  9 D),as well as in the corynoxenine treated group (Fig 6A,D) .In addition the opposite 2 5 0 result also obtained in ACB pretreating groups compared with the groups pretreated 2 5 1 with MLA or si-RNA. selectively and destroys tumor cells without damaging healthy cells [19, 20] . Thus, 2 7 2 selective killing has a higher efficiency accompanied by lower side effects. The homologous with the 30-56 amino acid sequence in λ -bungarotoxin, which binds 2 7 5 nAChRs. Therefore RVG has similar inhibiting effects as λ -bungarotoxin and has not 2 7 6
MEK/ERK signaling pathway was involved in rL-RVG-lowing migration of
only oncolytic effects but also blocks nAChRs by competitive antagonism which is a 2 7 7 common mechanism of many pharmacological drugs. Thus, rL-RVG plays an role as 2 7 8 competitive antagonist of α 7-nAChR after infecting gastric cancer cell lines such as 2 7 9 BGC and SGC. 
pentamers.
α 7-nAChR,another type of nAChR, has a positive effect on cancer cell 2 8 2 migration [21] .Nicotine and NNK could act as agonisst of α 7-nAChR to facilitate the 2 8 3 migration of gastric cancer cells [12, 22] and could indirectly activate ERK signaling 2 8 4 through promoting the release of epidermal growth factor (EGF) and trans-activation 2 8 5 of EGF receptors [23] .Moreover, the ERK signaling pathway also has influence on 2 8 6 EMT that may regulate expression of mesenchymal and epithelial repressor 2 8 7 genes [24] .In our study, we suggest that rL-RVG could lower the phosphorylation levels 2 8 8 of ERK signaling and decrease EMT in SGC and BGC cells, indicating that gastric 2 8 9 cancer cell migration which is suppressed by rL-RVG, is associated with the 2 9 0 MEK-ERK signaling pathway. It is of great significance to activate EMT for invasion and metastasis of gastric 2 9 2 cancer cells [25] .An aberrant EMT activation typically results in the transformation of 2 9 3 epithelial cells into mesenchymal cells and leads to phenotypic changes such as the 2 9 4 loss of cell-cell adhesion, cell polarity and acquisition of migratory and invasive 2 9 5 properties of cells. Cadherin is a significant component of adherent cell junctions. On 2 9 6 one hand, aberrant activation of EMT could transform E-cadherin to N-cadherin, 2 9 7 which is typically found in mesenchymal cells and could promote the formation of 2 9 8 adhesions between cells and the stroma [26] .On the other hand, Vimentin is a 2 9 9 widespread mesenchymal intermediate filament which results in adhesion and 3 0 0 migration in activated cells [27] and is a hallmark of aberrant EMT activation in 3 0 1 gastric cancer [28] . Our previous studies suggest that rL-RVG promotes apoptosis of 3 0 2 gastric cancer cells [14, 29] but the effect of rL-RVG on gastric cancer migration and its 3 0 3 underlying mechanism remain unknown. In this study, our results show for the first of gastric cancer cells via the α 7-nAChR pathway [12] . Thus we hypothesized that 3 0 9
rL-RVG might suppress the migration of cancer cells via α 7-nAChR. To demonstrate 3 1 0 this we used ACB, MLA and si-RNA of α 7-nAChR to pre-treat SGC cells and our 3 1 1 results further confirmed our hypothesis. 3 1 2 Previous studies suggest that the ERK signaling pathway plays an important role in 3 1 3 the proliferation, migration and apoptosis of cells [30] [31] . Therefore, inhibiting the ERK 3 1 4 signaling pathway strengthens the anti-tumor activity of gimatecan in gastric 3 1 5 cancer [32] . Activation of ERK signaling results in the promotion of cervical cancer cell 3 1 6 growth and metastasis [33] . Interestingly, we found that rL-RVG reduces the 3 1 7 phosphorylation levels of MEK/ERK and rseulted in a decrease of phosphorylation 3 1 8 levels in MLA ,α7-nAChR and si-RNA pre-treated groups compared to the ACB 3 1 9 pre-treated group. Additionally, we also achieved similar results in the change of EMT may induce EMT via ERK signaling pathways [34] .In our study, after pretreating with 3 2 2 Western blot analysis of α 7-nAChR, MEK/ERK signaling pathway and 3 7 2 epithelial/mesenchymal protein marker. b. Cell migration was detected by wound 3 7 3
healing and transwell assay. c.Immunofluorescence analysis of P-ERK. d. 3 7 4 Immunofluorescence analysis of EMT proteins E-cadherin in infected SGC cells. signaling pathway and epithelial/mesenchymal proteins and migration of cells. a. 3 8 0 Western blot analysis of the α 7-nAChR, MEK/ERK signaling pathway and 3 8 1 epithelial/mesenchymal protein markers. b. Cell migration was detected by wound 3 8 2 healing and transwell assay. c. Immunofluorescence analysis of P-ERK. d. 3 8 3 Immunofluorescence analysis of EMT markers E-cadherin in infected SGC cells. Figure 5 Effects of rL-RVG and si-RNA pretreated SGC cells on the α 7-nAChR, 3 8 9 MEK/ERK signaling pathway and epithelial/mesenchymal proteins and cell migration. and SGC cells were pretreated with rL-RVG, NDV or PBS for 24 h and then 4 1 1
subcutaneously injected into axillary subcutaneous tissues of adult female 4 1 2
athymic-nude mice. The subcutaneous tumor was examined after two weeks post 4 1 3 treatment. *P<0.5,**P<0.01.(rL-RVG vs NDV and PBS groups, respectively). 
